New game
Download
SCORM download
To be used in an LMS (Moodle, Blackboard...)
Regular download
To be published on a website or blog.
Downloading games is an exclusive feature for users with an Academic Plan or a Commercial Plan.
Get your Academic Plan or your Commercial Plan now and start integrating your games into your LMS, website or blog.
Get Academic Plan
If you wish, you can download a demo game here and test its integration:
Share game
Alphabet
Alphabet

Rosco OncoLatina

Integrate it into your platform
G. Classroom M. Teams
You can integrate the game into an LMS compatible with LTI 1.1 or LTI 1.3 such as Canvas, Moodle, or Blackboard. This way, the scores will be automatically saved into the platform’s gradebook.
Download
You have exceeded the maximum number of games you can integrate into Google Classroom with your current Plan.

To integrate as many games as you want in Google Classroom, you need an Academic Plan or a Commercial Plan.

Get Academic Plan
You have exceeded the maximum number of games you can integrate into Microsoft Teams with your current Plan.

To integrate as many games as you want in Microsoft Teams, you need an Academic Plan or a Commercial Plan.

Get Academic Plan
Downloading games is an exclusive feature for users with an Academic Plan or a Commercial Plan.

Get your Academic Plan or your Commercial Plan now and start integrating your games into your LMS, website or blog.

If you wish, you can download a demo game here and test its integration:

Get Academic Plan

Rosco OncoLatina

Alphabet

Played 3
Create copy

About this activity

Rosco OncoLatina

Created by

Lorena Moran
Lorena Moran
Argentina

Download the paper version to play

Make your own free game from our game creator
Compete against your friends to see who gets the best score in this game
Make challenge

Top Games

 %
Anonymous
Anonymous
 %
%
%
You have exceeded the maximum number of games you can print with your current Plan.

To print as many games as you want, you need an Academic Plan or a Commercial Plan.

Get Academic Plan
Print your game
Rosco OncoLatina
 

Rosco OncoLatinaOnline version

Rosco OncoLatina

by Lorena Moran
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Empieza por A

The most common age group in which AML is diagnosed, typically associated with different biology and prognosis compared to pediatric cases.

Empieza por B

A leading hematology journal publishing pivotal AML trials and ELN updates.

Empieza por C

A measurable clinical endpoint indicating disappearance of detectable leukemia after treatment.

Empieza por D

A potentially life-threatening inflammatory complication associated with IDH inhibitors and differentiating agents.

Empieza por E

European expert network providing AML genetic risk classification standards.

Empieza por F

AML patients eligible for intensive induction chemotherapy based on clinical assessment.

Empieza por G

Prognostic classification in AML based on cytogenetic and molecular abnormalities.

Empieza por H

Prognostic category defined by adverse cytogenetics or molecular abnormalities according to ELN classification.

Empieza por I

Oral targeted therapy inhibiting mutant IDH1 in AML.

Empieza por J

High-impact oncology journal frequently publishing pivotal AML phase III trials.

Empieza por K

The chromosomal profile used to define cytogenetic prognosis in AML.

Empieza por L

Clonal malignant disorder of myeloid precursors defined by 20% blasts in bone marrow.

Empieza por M

Highly sensitive technique used to detect residual leukemic cells after treatment.

Empieza por N

Frequent hematologic complication in AML patients, either disease-related or treatment-induced, increasing infection risk.

Empieza por O

Gold-standard survival endpoint measuring time from treatment initiation to death from any cause.

Empieza por P

Predicted clinical course of AML based on genetic and clinical variables.

Empieza por Q

Cardiac parameter that must be monitored with certain targeted AML therapies.

Empieza por R

Return of leukemic blasts after achieving remission.

Contiene la S

A composite clinical endpoint that may include CR, CRi, and CRh.

Empieza por T

Three-drug regimen increasingly investigated in molecularly defined AML subgroups.

Empieza por U

AML patients not eligible for intensive chemotherapy.

Empieza por V

BCL-2 inhibitor that transformed outcomes in combination with HMAs in elderly AML patients.

Contiene la W

A laboratory parameter often elevated at AML diagnosis reflecting disease burden.

Contiene la X

A critical safety parameter in AML therapy that may require dose adjustment or treatment interruption.

Empieza por Y

Unit of time commonly used to report long-term survival outcomes in AML trials.

Contiene la Z

An epigenetic regulator gene frequently mutated in AML and under therapeutic investigation.

 
Are you sure you want to leave the page?

If you leave, you will lose the game in progress.